Sargent Reports 1,006,300-Share Passive Holding in PAVmed (5.79%)

Rhea-AI Filing Summary

PAVmed Inc.'s Schedule 13G shows that Sargent Investment Group, LLC reports beneficial ownership of 1,006,300 common shares, representing 5.79% of the class. The filing identifies Sargent as an investment adviser organized in Maryland and indicates the position is held in the ordinary course of business as a passive holding under the Schedule 13G rules.

The filing discloses that Sargent does not hold sole voting power over the shares while it does report power to dispose of or direct disposition for the full amount. The statement also notes that other persons may have rights to dividends or sale proceeds, implying the economic interests are held on behalf of others rather than reflecting a controlling stake.

Positive

• The filing discloses a material institutional stake of 1,006,300 shares (5.79%), indicating notable investor interest in PAVmed.
• The position is reported on Schedule 13G, signaling the stake is held passively and not intended to influence control under the filing's certification.

Negative

• The filer reports no sole voting power over the shares, limiting direct governance influence.
• The statement notes that other persons may have rights to dividends or sale proceeds, indicating the economic interest may belong to third-party clients rather than Sargent directly.

Insights

Securities Analyst

TL;DR: Sargent holds a material passive stake (5.79%) in PAVmed, signaling institutional interest without intent to influence control.

The filing reports 1,006,300 shares (5.79%) held by Sargent Investment Group, classified under Schedule 13G as a passive investment adviser. From an investor perspective, a >5% stake is material because it flags institutional ownership and monitoring, but the Schedule 13G designation and the absence of sole voting power indicate no announced effort to change governance. The note that others may have rights to proceeds suggests fiduciary or client relationships rather than direct strategic positioning.

Corporate Governance Expert

TL;DR: The disclosure is material but neutral for control; voting and economic rights appear split between Sargent and third parties.

The filing documents that Sargent reports power to dispose of the reported shares while lacking sole voting authority, and it explicitly states other parties may be entitled to dividends or sale proceeds. That structure typically reflects an adviser-client arrangement where the adviser manages assets for clients. For governance impact, this reduces the likelihood of coordinated shareholder activism from this holder, making the disclosure noteworthy but not destabilizing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PAVmed Inc.

(Name of Issuer)

Common

(Title of Class of Securities)

70387R403

(CUSIP Number)

07/01/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 70387R403

1

Names of Reporting Persons

Sargent Investment Group, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,006,300.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,006,300.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PAVmed Inc.
(b)	Address of issuer's principal executive offices: 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Item 2.
(a)	Name of person filing: Sargent investment Group, LLC.
(b)	Address or principal business office or, if none, residence: 4920 Elm Street, Suite 305, Bethesda, Maryland 20814
(c)	Citizenship: Maryland, United States
(d)	Title of class of securities: Common
(e)	CUSIP No.: 70387R403
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1006300
(b)	Percent of class: 5.79%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1006300
	(iii) Sole power to dispose or to direct the disposition of: 1006300
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Other persons have the right to receive the proceeds from the sale of the securities reported herein.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Sargent Investment Group, LLC

Signature:	Kevin Kim
Name/Title:	Compliance Officer
Date:	08/14/2025

FAQ

What stake does Sargent Investment Group report in PAVmed (PAVMZ)?

Sargent Investment Group reports beneficial ownership of 1,006,300 shares, representing 5.79% of PAVmed's common stock.

Is the Sargent stake in PAVmed reported as active or passive (PAVMZ)?

The stake is reported on a Schedule 13G, indicating the position is held as a passive investment under the applicable rules.

Does Sargent have voting control over the reported PAVmed (PAVMZ) shares?

The filing states Sargent has no sole voting power over the shares and reports shared voting power as applicable.

Does the filing indicate the shares are held on behalf of others for PAVmed (PAVMZ)?

Yes. The filing notes that other persons have the right to receive proceeds or dividends, suggesting the shares may be held for clients or third parties.

What type of entity is Sargent Investment Group as listed in the filing?

Sargent Investment Group is identified as an investment adviser organized in Maryland.